SFS
SRRA

Sowell Financial Services’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Sowell Financial Services’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-871
Closed -$16K – 3083
2021
Q1 		$16K Buy
+871
New +$13.8K ﹤0.01% 2145

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Sowell Financial Services's SRRA Position: Q2 2021 in Review

Sowell Financial Services sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2021, closing a stake of 871 shares — an estimated $16K sold.

Sowell Financial Services first reported a position in SRRA in Q1 2021 and held it in 1 quarter. The position peaked at $16K in Q1 2021. 34 funds tracked by Wall St. Rank hold SRRA as of Q2 2021.

  • Sowell Financial Services reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 871 Sierra Oncology, Inc. Common Stock shares in Q2 2021, an estimated $16K.
  • Sowell Financial Services first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Sierra Oncology, Inc. Common Stock position peaked at $16K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.